Siilo www.siilo.com , a leading medical messaging platform with over 550,000 users, is now globally rebranding to Doctolib Siilo, including the Netherlands and Belgium. This represents the successful integration of Siilo into Doctolib Siilo (Doctolib announced the acquisition of Siilo earlier in 2023). The rebranding also signals a future where Siilo benefits from the innovation and leadership of Doctolib  www.doctolib.fr , enhancing its commitment to healthcare professionals and patient care.

Doctolib now supports over 900,000 professional users in health care, among others and serves 80 million people across Europe. With offices in 30+ cities and 2,800 team members, the brand is bringing its innovation to the Benelux, a region where Siilo has a strong presence.

Stanislas Niox-Chateau, CEO and co-founder of Doctolib, commented: “The rebranding of Siilo to Doctolib Siilo is not just a change of name, but a symbol of our shared vision for a more connected and efficient healthcare system. We are excited to bring the combined strengths of Doctolib and Siilo to healthcare professionals, promising an enhanced experience with continued trust and reliability.”

With the integration of Siilo into the Doctolib ecosystem, a new horizon of innovation opens up for the renowned medical messaging application. This strategic move not only retains Siilo’s
core functionalities but also anticipates future enhancements with Doctolib’s advanced technological resources.